Cancer Vaccines Adverse Effects
Mostrando 1-3 de 3 artigos, teses e dissertações.
-
1. Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
Despite being more than ten years since its introduction, global acceptance to the human papillomavirus (HPV) vaccine is still low. The immunogenetic background of the host, and HPV antigen recognition, are important in natural HPV infection, and should be taken into account in the understanding of adverse autoimmune reactions by the HPV vaccine in certain g
Mem. Inst. Oswaldo Cruz. Publicado em: 28/05/2018
-
2. Gene therapy of advanced-stage head and neck squamous cell carcinoma with Mycobacterium leprae heat shock protein 65 DNA: a phase 1 study / Fase 1 do estudo da aplicação da vacina de DNA HSP 65 (Heat Shock Protein) do Mycobacterium leprae no tratamento de formas avançadas de carcinomas epidermóide de cabeça e pescoço
This study goal was to describe and graduate the local and systemic toxicity of intratumoral injections of HSP (Heat Shock Protein) 65 DNA vaccine in advanced-stage head and neck squamous cell carcinoma (SCCHN) patients and to define the highest well tolerated dose for them. This is a prospective, non-randomized, uncontrolled, phase 1 study, using a new vacc
Publicado em: 2007
-
3. Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara
Potent and safe vaccinia virus vectors inducing cell-mediated immunity are needed for clinical use. Replicating vaccinia viruses generally induce strong cell-mediated immunity; however, they may have severe adverse effects. As a vector for clinical use, we assessed the defective vaccinia virus system, in which deletion of an essential gene blocks viral repli
American Society for Microbiology.